Acrivon Therapeutics, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acrivon Therapeutics, Inc. Common Stock generated cash of -$42,641,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,554,000 last year. Net change in cash is therefore $6,522,000.
Cash Flow
| 2020 | -2.80M | -15K | 2.88M |
|---|---|---|---|
| 2021 | -13.98M | -238K | 112.22M |
| 2022 | -30.11M | -141.67M | 101.70M |
| 2023 | -42.64M | 50.71M | -1.55M |
ACRV Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 29.90M | 99.99M | 1.99M | 1.91M |
Operating activities | ||||
Net income | -60.38M | -31.16M | -16.24M | -5.30M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 536K | 364K | 37K | 13K |
Stock-based compensation expense | 11.61M | 2.18M | 497K | 3K |
| Deferred income tax benefit | 11.61M | 2.18M | 497K | 3K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 3.60M | -245K | 798K | 81K |
Cash generated by operating activities | -42.64M | -30.11M | -13.98M | -2.80M |
Investing activities | ||||
Purchases Of Investments | -56.52M | -150.17M | 0 | 0 |
Investments In Property Plant And Equipment | -1.28M | -2.16M | -238K | -15K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 50.71M | -141.67M | -238K | -15K |
Financing activities | ||||
Common Stock Issued | -257K | 104.45M | 112.22M | 2.83M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -58K |
Cash used in financing activities | -1.55M | 101.70M | 112.22M | 2.88M |
Net Change In Cash | 6.52M | -70.08M | 98.00M | 71K |
Cash at end of period | 36.42M | 29.90M | 99.99M | 1.99M |
| Data source | Data source |